Pretomanid (Pa)

DRUG4 trials

Sponsors

Michael Hoelscher, University College, London, Shenzhen Third People's Hospital, Wuhan Pulmonary Hospital

Conditions

Efficacy and SafetyOther Specified Pulmonary TuberculosisPulmonary Tuberculosis

Phase 2

PanACEA - STEP2C -01

RecruitingNCT05807399

Michael HoelscherOther Specified Pulmonary Tuberculosis, Pulmonary Tuberculosis

Start: 2023-04-14End: 2027-12-30Target: 390Updated: 2025-10-07

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

RecruitingNCT06114628

University College, LondonPulmonary Tuberculosis

Start: 2024-01-09End: 2027-08-11Target: 2500Updated: 2025-10-06

Phase 3

A PAN-USR TB Multi-Center Trial

RecruitingNCT06905522

Shenzhen Third People's HospitalPulmonary Tuberculosis

Start: 2025-06-18End: 2029-12-31Target: 610Updated: 2025-12-01

Unknown Phase

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Not yet recruitingNCT07126639

Wuhan Pulmonary HospitalEfficacy and Safety

Start: 2025-09-01End: 2028-09-30Target: 200Updated: 2025-08-17